The organisation and results of first screening round of the Hungarian nationwide organised breast cancer screening programme

Boncz, I; Sebestyén, Andor; Döbrőssy, Lajos; Péntek, Z; Budai, András; Kovács, Attila; Dózsa, Csaba; Ember, István

doi:10.1093/annonc/mdl489

Cited by 32 publications

(22 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Other countries in Europe have reported much lower cancer detection rates, e.g. 3.7 per 1000 screened in Finland and 3.6 per 1000 screened in Hungary (19,20). A similar study in Egypt had a cancer detection rate of 4.3 per 1000, which is comparable to our study (21).…”

Section: Discussionsupporting

confidence: 86%

Breast cancer screening programme: experience from Eastern province, Saudi Arabia

Mulhim

Syed²,

Bagatadah³

et al. 2015

Easter Mediterr Health J

View full text Add to dashboard Cite

Programmes for early diagnosis of breast cancer are lacking in most countries in the Eastern Mediterranean Region. This paper reviews a nongovernmental screening programme launched in October 2009 in the Eastern Province of Saudi Arabia, in which 14 health centres were covered by 2 mobile mammography machines. Annual screening was offered to all women aged 40 years and above. Up to February 2014 a total of 8061 women were screened, an uptake rate of 15.0%. The recall rate was 7.9%. The number of cancers detected was 47, a cancer detection rate of 5.83 per 1000 women screened; 70.2% of the cancers detected had either no mass or the lesions were smaller than 2 cm. The mean age of women with cancer was 50.4 (SD 7.6) years. The screening parameters of our study correlated well with international standards. Despite the controversies regarding universal breast cancer screening, a national breast cancer screening programme for Saudi Arabia is needed.

show abstract

Section: Discussionsupporting

confidence: 86%

Breast cancer screening programme: experience from Eastern province, Saudi Arabia

Mulhim

Syed²,

Bagatadah³

et al. 2015

Easter Mediterr Health J

View full text Add to dashboard Cite

show abstract

“…In addition to these CRC screening pilots, nationwide population-based screening programmes for breast [20][21][22] and cervical [23][24][25] cancers were introduced in Hungary in 2002 and 2003 respectively, to address the high breast and cervical cancer mortality. Although there is a political interest for prostate cancer screening, scientific evidence on the efficacy of prostate screening is still very limited and thus under consideration [26][27][28].…”

Section: Screening For Colorectal Cancermentioning

confidence: 99%

The disease burden of colorectal cancer in Hungary

Boncz

Brodszky

Péntek³

et al. 2009

Eur J Health Econ

View full text Add to dashboard Cite

The aim of the paper is to give an overview of the epidemiology, treatment pattern and quality, as well as policy issues and disease burden of colorectal cancer (CRC) in Hungary. Colorectal cancer is the second most common cause of cancer-related death in both males and females in Hungary. The Hungarian Cancer Registry collects data on the epidemiological characteristics of CRC. Two pilot programmes (1997/1998 and 2003/2004) were conducted for population-based screening of CRC using both immunological and guaiac faecal occult blood testing (FOBT). The National Health Insurance Fund Administration (NHIFA) spends altogether 38.9 million a year on the treatment of CRC. It is hoped that the introduction of an accepted and cost-effective screening programme for CRC can reduce the high CRC burden in Hungary.

show abstract

“…In Poland [33] and Hungary [34], non-eligible women are defined as those who have undergone surgical treatment for BC. In Switzerland, gynaecologists and radiologists have agreed that BC survivors need closer medical follow-up outside organised screening programmes [35].…”

Section: Discussionmentioning

confidence: 99%

Should breast cancer survivors be excluded from, or invited to, organised mammography screening programmes?

Bucchi

2011

BMC Health Serv Res

View full text Add to dashboard Cite

BackgroundThe prevalence of breast cancer in developed countries has steadily risen over recent decades. Immediate and long-term health needs of patients, including preventive care and screening services, are receiving increasing attention. A question still unresolved is whether breast cancer survivors should receive mammographic surveillance in the clinical or screening setting and, thus, whether they should be excluded from, or invited to, organised mammography screening programmes. The objective of this article is to discuss the many contradictory aspects of this matter.DiscussionProblems with mammographic surveillance of breast cancer survivors include: weak evidence of a reduction in mortality; lack of evidence in favour of one setting or the other; lack of evidence-based guidelines for the frequency and duration of surveillance; disproportionate emphasis placed on the first few years post-treatment, probably dictated by surgical and oncological priorities; a variety of screening policies, as these women are permanently or temporarily or partially excluded from many - but not all - organised screening programmes worldwide; an even greater disparity in follow-up protocols used in the clinical setting; a paucity of data on compliance to mammographic surveillance in both settings; and a difficulty in coordinating the roles of health care providers. In the future, the use of mammography in breast cancer survivors will be influenced by the inclusion of women aged > 69 years in organised screening programmes and the implementation of multidisciplinary breast units, and will probably be investigated by research activities on individual risk assessment and risk-tailored screening. In the interim, current problems can be partially alleviated with some technical solutions in screening data recording, patient flows, and care coordination.SummaryMammographic surveillance of breast cancer survivors is situated at the crossroads of numerous different specialist areas of breast cancer control and management. The solutions for current problems probably lie in some important modifications in the conventional screening procedure that are underway or under study. These developments appear to be directed towards a partial modification of the screening rationale, with an adaptation to meet the diversified breast care needs of women. The complexity of the matter constitutes a call to action for several entities to eliminate the barriers to effective research in this field.

show abstract

The organisation and results of first screening round of the Hungarian nationwide organised breast cancer screening programme

Abstract: There is therefore an urgent need to closely monitor performance and to review programme policies and procedures with the aim of increasing both the participation rate and the proportion of women eligible to attend screening.

Cited by 32 publications

References 21 publications

Breast cancer screening programme: experience from Eastern province, Saudi Arabia

Breast cancer screening programme: experience from Eastern province, Saudi Arabia

The disease burden of colorectal cancer in Hungary

Should breast cancer survivors be excluded from, or invited to, organised mammography screening programmes?

Contact Info

Product

Resources

About